Oregon Joined Genomic Newborn Screening Study
The statewide research program expands genetic testing for infants to include over 700 rare conditions.
Updated on Oct. 12, 2026 in Babies

Live Poll
Should medical systems prioritize expanded genetic screening for newborns despite potential risks?
Oregon has launched participation in the BRIDGES-NBS research study, which screens newborns for more than 700 genetic conditions. This program works alongside the state's existing screening protocols to identify health issues early.
Why it matters
Traditional screening programs are unable to keep pace with rapid medical advancements, and this study aims to facilitate treatment within an infant's first year of life. The initiative explores the effective implementation of genomic technology and post-diagnosis care for families.
The BRIDGES-NBS program offers genomic testing for over 700 genetic conditions, a significant increase over the 46 conditions covered by standard screening. The state's initial newborn screening program has been in operation since 1963.
The players
OHSU
The Oregon Health & Science University acts as a primary enrollment site for the new genomic study.
PeaceHealth Sacred Heart Medical Center RiverBend
This medical center serves as an authorized location where families can enroll their newborns in the study.
The details
The program analyzes infant DNA for genetic abnormalities using a standard blood sample provided by participating families. Enrollment is free for any baby born in Oregon and can be managed through OHSU, PeaceHealth Sacred Heart Medical Center RiverBend, or independently.
Timeline
The regular newborn screening program was established in 1963.
Culture Shift
This program reflects a broader societal shift toward personalized medicine and the proactive use of genomic data to manage long-term health outcomes. It signals a move away from legacy screening methods toward more comprehensive early diagnostic capabilities for families.
Families in Oregon can choose to participate in this free study to gain additional genetic health insights for their newborns without replacing required screenings. Participation requires coordination with designated medical centers or independent enrollment processes.
The takeaway
Families interested in genomic screening should speak with their healthcare providers to determine if enrollment in the study is appropriate for their child. This program provides an optional resource for early detection that exceeds the scope of standard state-mandated testing.
Further reading
Learn more about infant health services and research in the Babies section.
Source note: This article includes information reported by Opb.
Live Poll
Should medical systems prioritize expanded genetic screening for newborns despite potential risks?










